Hindustan Bio Sciences share price
BSE: 532041IT - SoftwareSmall Cap
Last close ₹6.90down ₹0.08 (1.15%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹6.98.
52-week range of traded prices to 23 Oct 2026
₹5.00Low, 29 Dec 2025₹9.92High, 23 Apr 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7.07 Cr4,780th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 8.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 2.84
- Volume, BSEVolume. Shares traded on the last trading day.
- 5,976
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026Filed 31 Jul
- Revenue
- ₹0.00 Cr
- Net profit
- −₹0.11 Cr
Revenue by year
Peak revenue ₹3.56 Cr, year to Mar 2019
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2026, −₹0.08 CrA loss in 6 of the 10 years shown
| ₹ crore | Sep 2024Filed 30 Oct | Dec 2024 | Mar 2025Filed 13 Jun | Jun 2025Filed 31 Jul | Sep 2025Filed 31 Oct | Dec 2025Filed 31 Jan | Mar 2026 | Jun 2026Filed 31 Jul |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | – | 0.38 | 0.32 | 0.00 | 0.38 | – | 0.00 |
| Net profit | −0.05 | – | 0.11 | 0.01 | −0.06 | 0.08 | – | −0.11 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | – | – | 28.8% | 4.3% | – | 21.4% | – | – |
Standalone. The last eight quarters. The latest is shaded. No results on record for the quarters to Dec 2024 and Mar 2026.
Business segments
In the year to Mar 2026 the company reports one business segment, TRADING OF PHARMACUITICALS, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: less than a year of results in a row on record. Not shown, EV/EBITDA: less than a year of results in a row on record. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 42% of 1,126 trading days over the last 5 years.
LowestHighest
Its median9.2Industry median1.5
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +11.3% | – | – | 0.0% |
| 3 years | +13.5% | – | – | 0.0% |
| 5 years | +21.0% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Software Products, 54 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Hindustan Bio Sciences in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.
Hindustan Bio Sciences is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Groarc Industries IndiaGROARC | 11 | 5.2 | 0.3 | 9.5 | +1,041.4% | – | 5.4% | 2.8% | 0.00% |
 Hit Kit Global SolutionsHITKITGLO | 11 | 129.6 | 0.9 | 872.6 | +30.8% | – | 0.7% | 0.1% | 0.00% |
 Svam SoftwareSVAMSOF | 11 | – | 0.6 | – | +167.1% | – | −0.6% | −2.6% | 0.00% |
 Clio InfotechCLIOINFO | 10 | 14.0 | 0.6 | 33.7 | +1,608.9% | +2,082.2% | 5.5% | 1.9% | 0.00% |
 Seshachal TechnologiesSESHACHAL | 5 | – | 3.0 | – | +215.2% | −121.9% | −1.5% | −1.6% | 0.00% |
 Nihar Info GlobalNIHARINF | 5 | – | 0.7 | 4.2 | +123.7% | – | – | 18.0% | 0.00% |
 Omni Axs SoftwareOMNIAX | 5 | – | 0.4 | – | – | – | – | – | 0.00% |
 Women NetworksWOMENNET | 4 | – | 0.6 | – | – | −846.8% | −7.6% | −1.4% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Aug 2026
31 Aug · Board meeting
26 Aug · Board meeting
Meeting on 31 Aug 2026: reduction of capital
Hindustan Bio Sciences share price by year
Each calendar year to 2025.Hindustan Bio Sciences share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 5.27 | −48.4% | 10.32 | 5.03 |
| 2024 | 10.21 | +14.5% | 13.46 | 6.97 |
| 2023 | 8.92 | +135.4% | 14.46 | 3.68 |
| 2022 | 3.79 | −29.9% | 5.96 | 3.14 |
| 2021 | 5.41 | +18.4% | 5.41 | 2.67 |
| 2020 | 4.57 | +118.7% | 4.57 | 1.00 |
| 2019 | 2.09 | +102.9% | 3.18 | 0.77 |
| 2018 | 1.03 | +178.4% | 1.03 | 0.38 |
| 2017 | 0.37 | −83.4% | 2.50 | 0.37 |
| 2016 | 2.23 | −43.8% | 4.99 | 1.38 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2019 is from its first session, 11 Feb 2019. The 2018 close is its last trade, on 8 Oct 2018.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 6.98 | 6.98 | 6.64 | 6.90 | 6.72 | 5,976 |
| 22 Oct 2026 | 6.83 | 7.04 | 6.77 | 6.98 | 6.79 | 488 |
| 21 Oct 2026 | 6.61 | 7.24 | 6.61 | 6.77 | 7.04 | 8,124 |
| 19 Oct 2026 | 6.90 | 6.96 | 6.75 | 6.90 | 6.84 | 3,754 |
| 16 Oct 2026 | 6.89 | 7.20 | 6.70 | 7.10 | 6.79 | 4,192 |
| 15 Oct 2026 | 6.80 | 7.20 | 6.63 | 6.98 | 7.05 | 3,208 |
| 14 Oct 2026 | 7.22 | 7.22 | 6.90 | 6.92 | 6.99 | 12,382 |
| 13 Oct 2026 | 7.70 | 7.70 | 7.22 | 7.25 | 7.29 | 12,966 |
| 12 Oct 2026 | 7.34 | 7.80 | 7.08 | 7.60 | 7.22 | 7,530 |
| 9 Oct 2026 | 7.37 | 7.56 | 7.29 | 7.45 | 7.30 | 2,314 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 11 May 2023 | Price move | – | This is the share's first trade after a corporate action (Reduction of Capital, ex-date 3 Mar 2023), and the action's terms do not account for the move. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- Legal name
- Hindustan Bio Sciences Ltd.
- BSE code
- 532041
- ISIN
- INE597C01021
- Industry
- IT - Software
- Listed
- Oct 1996
- Face value
- ₹2
- CIN
- L26942TG1991PLC013564
- Corporate identity number, the registrar of companies' code for it